Edition:
United Kingdom

Repligen Corp (RGEN.OQ)

RGEN.OQ on NASDAQ Stock Exchange Global Select Market

55.15USD
19 Oct 2018
Change (% chg)

$-1.36 (-2.41%)
Prev Close
$56.51
Open
$56.54
Day's High
$57.77
Day's Low
$54.92
Volume
114,897
Avg. Vol
125,606
52-wk High
$58.99
52-wk Low
$29.58

Chart for

About

Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products. It... (more)

Overall

Beta: 1.07
Market Cap(Mil.): $1,667.74
Shares Outstanding(Mil.): 43.51
Dividend: --
Yield (%): --

Financials

  RGEN.OQ Industry Sector
P/E (TTM): 75.20 30.90 33.64
EPS (TTM): 0.51 -- --
ROI: 6.40 14.75 14.27
ROE: 9.98 16.24 15.99

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $139.05 -0.45
Novartis AG (NOVN.S) CHF87.04 +1.16
Roche Holding Ltd. (ROG.S) CHF244.95 +6.40
Roche Holding Ltd. (RO.S) CHF245.20 +5.80
Merck & Co., Inc. (MRK.N) $72.35 +0.14
Sanofi SA (SASY.PA) €77.80 0.00
Amgen, Inc. (AMGN.OQ) $201.80 -0.92
Gilead Sciences, Inc. (GILD.OQ) $73.27 -0.90
Incyte Corporation (INCY.OQ) $66.06 +1.62

Earnings vs. Estimates